-
1دورية أكاديمية
المؤلفون: Cascinu, Stefano, Berardi, Rossana, Bianco, Roberto, Bilancia, Domenico, Zaniboni, Alberto, Ferrari, Daris, Mosconi, Stefania, Spallanzani, Andrea, Cavanna, Luigi, Leo, Silvana, Negri, Francesca, Beretta, Giordano D, Sobrero, Alberto, Banzi, Maria, Morabito, Alberto, Bittoni, Alessandro, Marciano, Roberta, Ferrara, Domenica, Noventa, Silvia, Piccirillo, Maria C, Labianca, Roberto, Mosconi, Cristina, Casadei Gardini, Andrea, Gallo, Ciro, Perrone, Francesco
المساهمون: Cascinu, Stefano, Berardi, Rossana, Bianco, Roberto, Bilancia, Domenico, Zaniboni, Alberto, Ferrari, Dari, Mosconi, Stefania, Spallanzani, Andrea, Cavanna, Luigi, Leo, Silvana, Negri, Francesca, Beretta, Giordano D, Sobrero, Alberto, Banzi, Maria, Morabito, Alberto, Bittoni, Alessandro, Marciano, Roberta, Ferrara, Domenica, Noventa, Silvia, Piccirillo, Maria C, Labianca, Roberto, Mosconi, Cristina, Casadei Gardini, Andrea, Gallo, Ciro, Perrone, Francesco
مصطلحات موضوعية: Advanced pancreatic cancer, Paclitaxel and gemcitabine, Phase II randomized trial, Adenocarcinoma, Adult, Aged, Albumin, Antineoplastic Combined Chemotherapy Protocol, Deoxycytidine, Female, Follow-Up Studie, Human, Male, Middle Aged, Paclitaxel, Pancreatic Neoplasm, Prognosi, Survival Rate
العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000644993500009; volume:148; firstpage:422; lastpage:429; numberofpages:8; journal:EUROPEAN JOURNAL OF CANCER; http://hdl.handle.net/11588/890495Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85105007363; https://pubmed.ncbi.nlm.nih.gov/33812334Test/
الإتاحة: https://doi.org/10.1016/j.ejca.2021.02.023Test
http://hdl.handle.net/11588/890495Test
https://pubmed.ncbi.nlm.nih.gov/33812334Test/ -
2دورية أكاديمية
المؤلفون: Orsi G., Di Marco M., Cavaliere A., Niger M., Bozzarelli S., Giordano G., Noventa S., Rapposelli I. G., Garajova I., Tortora G., Rodriquenz M. G., Bittoni A., Penzo E., De Lorenzo S., Peretti U., Paratore C., Bernardini I., Mosconi S., Spallanzani A., Macchini M., Tamburini E., Bencardino K., Giommoni E., Scartozzi M., Forti L., Valente M. M., Militello A. M., Cascinu S., Milella M., Reni M.
المساهمون: Orsi G., Di Marco M., Cavaliere A., Niger M., Bozzarelli S., Giordano G., Noventa S., Rapposelli I.G., Garajova I., Tortora G., Rodriquenz M.G., Bittoni A., Penzo E., De Lorenzo S., Peretti U., Paratore C., Bernardini I., Mosconi S., Spallanzani A., Macchini M., Tamburini E., Bencardino K., Giommoni E., Scartozzi M., Forti L., Valente M.M., Militello A.M., Cascinu S., Milella M., Reni M.
مصطلحات موضوعية: chemotherapy activity, chemotherapy dose intensity, chemotherapy toxicity, germline BRCA, pancreatic cancer, Antineoplastic Combined Chemotherapy Protocol, BRCA1 Protein, Cisplatin, Germ Cell, Human, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms
وصف الملف: ELETTRONICO
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34392104; info:eu-repo/semantics/altIdentifier/wos/WOS:000704803800010; volume:6; issue:5; firstpage:1; lastpage:10; numberofpages:10; journal:ESMO OPEN; http://hdl.handle.net/11585/857459Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85120346608; https://www.sciencedirect.com/science/article/pii/S205970292100199X?via=ihubTest
الإتاحة: https://doi.org/10.1016/j.esmoop.2021.100238Test
http://hdl.handle.net/11585/857459Test
https://www.sciencedirect.com/science/article/pii/S205970292100199X?via=ihubTest -
3
المؤلفون: M. Scartozzi, Giampaolo Tortora, Giulia Orsi, Alessandro Cavaliere, Emiliano Tamburini, A.M. Militello, E. Penzo, L.G. Forti, Michele Milella, I. Bernardini, M. Macchini, Silvia Noventa, Michele Reni, M.M. Valente, Monica Niger, Stefano Cascinu, Andrea Spallanzani, K. Bencardino, M. Di Marco, Ingrid Garajová, A. Bittoni, U. Peretti, S. Mosconi, Silvia Bozzarelli, Maria Grazia Rodriquenz, C. Paratore, I.G. Rapposelli, Guido Giordano, S. De Lorenzo, Elisa Giommoni
المساهمون: Orsi, G., Di Marco, M., Cavaliere, A., Niger, M., Bozzarelli, S., Giordano, G., Noventa, S., Rapposelli, I. G., Garajova, I., Tortora, G., Rodriquenz, M. G., Bittoni, A., Penzo, E., De Lorenzo, S., Peretti, U., Paratore, C., Bernardini, I., Mosconi, S., Spallanzani, A., Macchini, M., Tamburini, E., Bencardino, K., Giommoni, E., Scartozzi, M., Forti, L., Valente, M. M., Militello, A. M., Cascinu, S., Milella, M., Reni, M., Orsi G., Di Marco M., Cavaliere A., Niger M., Bozzarelli S., Giordano G., Noventa S., Rapposelli I.G., Garajova I., Tortora G., Rodriquenz M.G., Bittoni A., Penzo E., De Lorenzo S., Peretti U., Paratore C., Bernardini I., Mosconi S., Spallanzani A., Macchini M., Tamburini E., Bencardino K., Giommoni E., Scartozzi M., Forti L., Valente M.M., Militello A.M., Cascinu S., Milella M., Reni M.
المصدر: ESMO Open
مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, FOLFIRINOX, medicine.medical_treatment, pancreatic cancer, Gastroenterology, Germ Cell, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Original Research, chemotherapy toxicity, Cisplatin, Chemotherapy, Antineoplastic Combined Chemotherapy Protocol, business.industry, BRCA1 Protein, Carcinoma, Gemcitabine, Oxaliplatin, Irinotecan, Pancreatic Neoplasms, Germ Cells, Oncology, chemotherapy activity, Fluorouracil, Pancreatic Ductal, germline BRCA, chemotherapy dose intensity, Toxicity, business, medicine.drug, Human, Carcinoma, Pancreatic Ductal
وصف الملف: ELETTRONICO
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79c3d6ecae6dfd5240f9890e44c4b137Test
-
4
المؤلفون: Francesca Negri, Maria Banzi, Andrea Spallanzani, Francesco Perrone, Alberto Sobrero, Roberto Bianco, Andrea Casadei Gardini, Luigi Cavanna, Daris Ferrari, Ciro Gallo, Maria Carmela Piccirillo, Rossana Berardi, Roberta Marciano, Silvia Noventa, Giordano D. Beretta, Alberto Zaniboni, Domenica Ferrara, Alberto Morabito, Roberto Labianca, Alessandro Bittoni, Silvana Leo, Stefano Cascinu, Domenico Bilancia, Stefania Mosconi, Cristina Mosconi
المساهمون: Cascinu, S., Berardi, R., Bianco, R., Bilancia, D., Zaniboni, A., Ferrari, D., Mosconi, S., Spallanzani, A., Cavanna, L., Leo, S., Negri, F., Beretta, G. D., Sobrero, A., Banzi, M., Morabito, A., Bittoni, A., Marciano, R., Ferrara, D., Noventa, S., Piccirillo, M. C., Labianca, R., Mosconi, C., Casadei Gardini, A., Gallo, C., Perrone, F., Cascinu, Stefano, Berardi, Rossana, Bianco, Roberto, Bilancia, Domenico, Zaniboni, Alberto, Ferrari, Dari, Mosconi, Stefania, Spallanzani, Andrea, Cavanna, Luigi, Leo, Silvana, Negri, Francesca, Beretta, Giordano D, Sobrero, Alberto, Banzi, Maria, Morabito, Alberto, Bittoni, Alessandro, Marciano, Roberta, Ferrara, Domenica, Noventa, Silvia, Piccirillo, Maria C, Labianca, Roberto, Mosconi, Cristina, Casadei Gardini, Andrea, Gallo, Ciro, Perrone, Francesco
مصطلحات موضوعية: 0301 basic medicine, Male, Cancer Research, medicine.medical_treatment, Gastroenterology, Deoxycytidine, law.invention, 0302 clinical medicine, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, Medicine, Advanced pancreatic cancer, Nab-paclitaxel, Unresectable Pancreatic Cancer, Pancreatic Neoplasm, Combination chemotherapy, Middle Aged, Prognosis, Survival Rate, Oncology, 030220 oncology & carcinogenesis, Female, medicine.drug, Human, Adult, medicine.medical_specialty, Paclitaxel, Prognosi, Locally advanced, Adenocarcinoma, Follow-Up Studie, 03 medical and health sciences, Phase II randomized trial, Internal medicine, Albumins, Humans, Aged, Chemotherapy, Antineoplastic Combined Chemotherapy Protocol, business.industry, Albumin, medicine.disease, Gemcitabine, Pancreatic Neoplasms, 030104 developmental biology, Paclitaxel and gemcitabine, business, Progressive disease, Follow-Up Studies
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c376e62a6b974a269dc1a734997b60dTest
http://hdl.handle.net/11591/461643Test -
5دورية أكاديمية
المؤلفون: M. Scartozzi, R. Giampieri, E. Maccaroni, A. Mandolesi, S. Biagetti, S. Alfonsi, L. Giustini, C. Loretelli, L. Faloppi, A. Bittoni, M. Bianconi, M. D. Prete, I. Bearzi, CASCINU, Stefano
المساهمون: M., Scartozzi, R., Giampieri, E., Maccaroni, A., Mandolesi, S., Biagetti, S., Alfonsi, L., Giustini, C., Loretelli, L., Faloppi, A., Bittoni, M., Bianconi, M. D., Prete, I., Bearzi, Cascinu, Stefano
مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodie, Monoclonal, administration /&/ dosage, Antineoplastic Combined Chemotherapy Protocol, therapeutic use, Camptothecin, administration /&/ dosage/analogs /&/ derivatives, Colorectal Neoplasm, drug therapy/enzymology/pathology, Female, Humans, Immunohistochemistry, Male, Middle Aged, Mitogen-Activated Protein Kinase, metabolism, Neoplasm Metastasis, Phosphorylation, Proto-Oncogene Proteins c-akt, Treatment Outcome
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/22490361; info:eu-repo/semantics/altIdentifier/wos/WOS:000308436400001; volume:10; firstpage:71; lastpage:71; numberofpages:1; journal:JOURNAL OF TRANSLATIONAL MEDICINE; http://hdl.handle.net/11380/1079195Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84862235601; http://dx.doi.org/10.1186/1479-5876-10-71Test
-
6
المؤلفون: Battelli, N., Bittoni, A., Pagliacci, A., Zepponi, L., Scartozzi, M., Mariotti, C., Stefano Cascinu
المساهمون: N., Battelli, A., Bittoni, A., Pagliacci, L., Zepponi, M., Scartozzi, C., Mariotti, Cascinu, Stefano
المصدر: Scopus-Elsevier
مصطلحات موضوعية: Oral, Adult, Cancer Research, dosage/adverse effects/analogs /&, Administration, Oral, Breast Neoplasms, Vinblastine, Deoxycytidine, Disease-Free Survival, Drug Administration Schedule, 030218 nuclear medicine & medical imaging, dosage/adverse effect, Dose-Response Relationship, 03 medical and health sciences, 0302 clinical medicine, Administration, Oral, Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, administration /&/ dosage/adverse effects, Breast Neoplasms, drug therapy, Deoxycytidine, administration /&/ dosage/adverse effects/analogs /&/ derivatives, Disease-Free Survival, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Fluorouracil, administration /&/ dosage/adverse effects/analogs /&/ derivatives, Humans, Middle Aged, Treatment Outcome, Vinblastine, administration /&/ dosage/adverse effects/analogs /&/ derivatives, Antineoplastic Combined Chemotherapy Protocols, Humans, Capecitabine, Aged, Antineoplastic Combined Chemotherapy Protocol, Dose-Response Relationship, Drug, Vinorelbine, General Medicine, Middle Aged, derivatives, drug therapy, derivative, Treatment Outcome, Oncology, 030220 oncology & carcinogenesis, administration /&, Female, Fluorouracil, Drug, Breast Neoplasm, Human
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4181d7db03a86da94a5585ef41041acdTest
https://doi.org/10.1177/030089161109700406Test -
7دورية أكاديمية
المؤلفون: M. Scartozzi, R. Giampieri, C. Loretelli, A. Bittoni, A. Mandolesi, L. Faloppi, M. Bianconi, M. Del Prete, K. Andrikou, I. Bearzi, S. Cascinu
المساهمون: M. Scartozzi, R. Giampieri, C. Loretelli, A. Bittoni, A. Mandolesi, L. Faloppi, M. Bianconi, M. Del Prete, K. Andrikou, I. Bearzi, S. Cascinu
مصطلحات موضوعية: cancer, chemotherapy, gastric, genotype, polymorphism, VEGF, Adult, Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocol, Disease-Free Survival, Drug Resistance, Neoplasm, Female, Human, Male, Middle Aged, Neoplasm Metastasi, Neovascularization, Pathologic, Prognosi, Stomach Neoplasm, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factor C, Vascular Endothelial Growth Factor Receptor-1, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor Receptor-3, Drug Therapy, Molecular Medicine, Genetic
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/24090479; info:eu-repo/semantics/altIdentifier/wos/WOS:000327377000017; volume:14; issue:16; firstpage:1991; lastpage:1998; numberofpages:8; journal:PHARMACOGENOMICS; http://hdl.handle.net/2434/570233Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84889059175
-
8دورية أكاديمية
المؤلفون: M. Scartozzi, C. Pierantoni, R. R. Silva, D. Mari, M. Pistelli, M. D. Prete, E. Galizia, LORETELLI, CRISTIAN, BERARDI, ROSSANA, GIAMPIERI, RICCARDO, FALOPPI, LUCA, MACCARONI, ELENA, BITTONI, ALESSANDRO, CASCINU, Stefano
المساهمون: M., Scartozzi, Loretelli, Cristian, Berardi, Rossana, C., Pierantoni, R. R., Silva, D., Mari, Giampieri, Riccardo, Faloppi, Luca, M., Pistelli, Maccaroni, Elena, Bittoni, Alessandro, M. D., Prete, E., Galizia, Cascinu, Stefano
مصطلحات موضوعية: Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocol, administration /&/ dosage/adverse effects/therapeutic use, Colorectal Neoplasm, drug therapy/genetics, DNA-Binding Protein, genetics, Dihydrouracil Dehydrogenase (NADP), Endonuclease, Female, Genotyping Techniques, Glucuronosyltransferase, Humans, Male, Pharmacogenetics, Thymidylate Synthase, Treatment Outcome
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/21893437; info:eu-repo/semantics/altIdentifier/wos/WOS:000301205000013; volume:44; firstpage:74; lastpage:79; numberofpages:5; journal:DIGESTIVE AND LIVER DISEASE; http://hdl.handle.net/11566/87643Test; http://hdl.handle.net/11566/71517Test; http://hdl.handle.net/11566/72222Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-83855160887; http://dx.doi.org/10.1016/j.dld.2011.08.006Test
الإتاحة: https://doi.org/10.1016/j.dld.2011.08.006Test
http://hdl.handle.net/11566/87643Test
http://hdl.handle.net/11566/71517Test
http://hdl.handle.net/11566/72222Test -
9دورية أكاديمية
المؤلفون: N. Battelli, A. Bittoni, A. Pagliacci, L. Zepponi, M. Scartozzi, C. Mariotti, CASCINU, Stefano
المساهمون: N., Battelli, A., Bittoni, A., Pagliacci, L., Zepponi, M., Scartozzi, C., Mariotti, Cascinu, Stefano
مصطلحات موضوعية: Administration, Oral, Adult, Aged, Antineoplastic Combined Chemotherapy Protocol, administration /&, / dosage/adverse effect, Breast Neoplasm, drug therapy, Deoxycytidine, / dosage/adverse effects/analogs /&, / derivative, Disease-Free Survival, Dose-Response Relationship, Drug, Drug Administration Schedule, Female, Fluorouracil, Human, Middle Aged, Treatment Outcome, Vinblastine, / derivatives
العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000295956300006; volume:97; firstpage:449; lastpage:453; numberofpages:4; journal:TUMORI; http://hdl.handle.net/20.500.11768/113054Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-80053629203; http://dx.doi.org/10.1700/950.10396Test
الإتاحة: https://doi.org/20.500.11768/113054Test
https://doi.org/10.1700/950.10396Test
https://hdl.handle.net/20.500.11768/113054Test -
10دورية أكاديمية
المؤلفون: Scartozzi M., Mandolesi A., Giampieri R., Bittoni A., Pierantoni C., Zaniboni A., Galizia E., Giustini L., Silva R. R., Bisonni R., Berardi R., Biscotti T., Biagetti S., Bearzi I., CASCINU, Stefano
المساهمون: Scartozzi, M., Mandolesi, A., Giampieri, R., Bittoni, A., Pierantoni, C., Zaniboni, A., Galizia, E., Giustini, L., Silva, R. R., Bisonni, R., Berardi, R., Biscotti, T., Biagetti, S., Bearzi, I., Cascinu, Stefano
مصطلحات موضوعية: Adult, Aged, 80 and over, Antibodie, Monoclonal, administration /&, / dosage, Antineoplastic Combined Chemotherapy Protocol, therapeutic use, Camptothecin, / dosage/analogs /&, / derivative, Colorectal Neoplasm, drug therapy/enzymology/genetics/pathology, Disease-Free Survival, Female, Gene, ra, Human, Immunohistochemistry, Male, Middle Aged, Mutation, Prognosi, Receptor, erbB-3, biosynthesis/genetic, Retrospective Studie, Treatment Outcome
العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000286506600006; volume:16; firstpage:53; lastpage:60; numberofpages:7; journal:THE ONCOLOGIST; http://hdl.handle.net/20.500.11768/113048Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-79952607191; http://dx.doi.org/10.1634/theoncologist.2010-0119Test
الإتاحة: https://doi.org/20.500.11768/113048Test
https://doi.org/10.1634/theoncologist.2010-0119Test
https://hdl.handle.net/20.500.11768/113048Test